Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • Movers
  • News

Chinese Drugmaker BeiGene And Novartis Move Out From Second Cancer Drug Pact

By Vandana Singh
September 19, 9:18 AM
BeiGene Ltd (NASDAQ: BGNE) said it would regain rights to develop, manufacture, and commercialize Tevimbra (tislelizumab), its cancer drug, from Novartis AG (NYSE: NVS).

BGNE

Read More
3 minute read
  • General
  • Global
  • Government
  • Large Cap
  • News
  • Regulations
  • Tech
  • Topics

Israel’s Netanyahu Tells Elon Musk To ‘Assume’ He’s US President

By AJ Fabino
September 18, 5:00 PM
As leaders in the artificial intelligence sector continue to make global appearances to world governments on AI regulation and safe adoption, Elon Musk on Monday found himself in a one-on-one session with Israeli Prime Minister Benjamin Netanyahu.

TSLA

Read More
2 minute read
  • Commodities
  • Economics
  • ETFs
  • Large Cap
  • Macro Economic Events
  • New ETFs
  • Sector ETFs
  • Tech

Is $100 Oil On The Horizon? Industry Experts Say Yes, Here’s Why

By Piero Cingari
September 18, 3:06 PM
As crude oil prices surge, experts are starting to bet on a barrel of oil hitting the coveted…

AAPL

Read More
2 minute read
  • Contracts
  • Equities
  • Large Cap
  • Markets
  • Media
  • Top Stories

Stellantis Proposes New Contract Potentially Resulting In Closure Of 18 US Facilities

By Piero Cingari
September 18, 2:51 PM
Automaker Stellantis N.V. (NYSE:STLA)’s latest contract proposal to the United Auto Workers union threatens to shutter 18 U.S. facilities. The clash between…

STLA

Read More
2 minute read
  • General
  • Global
  • Large Cap
  • Markets
  • News
  • Trading Ideas

Musk Accepts Erdogan’s Invitation To Teknofest Amid Talks Of Turkish Tesla Factory

By AJ Fabino
September 18, 12:31 PM
In a move that signals Turkey's ambitions to play a role in the electric vehicle (EV) sector, Turkish President Tayyip Erdogan proposed to Tesla Inc (NASDAQ: TSLA) CEO Elon Musk the idea of building a Tesla prod

TSLA

Read More
2 minute read
  • Dividends
  • General
  • Large Cap
  • Long Ideas
  • Markets
  • Mid Cap
  • News
  • Trading Ideas

Is ARM Holdings Stock Going To Pay Dividends?

By AJ Fabino
September 18, 12:30 PM
As Arm Holdings PLC - ADR (NASDAQ: ARM) enters its third day of trading on the open markets, after staging the year's biggest initial public offering on Thursday with a valuation of $54.5 billion, investors may be wondering if the company is planning on returning capital to

ARM

Read More
2 minute read
  • General
  • Global
  • Government
  • Large Cap
  • News
  • Regulations
  • Tech
  • Topics

AI At Crossroads As US, UK Leaders Tackle Tech Monopolies, Ethical Dilemmas

By AJ Fabino
September 18, 11:49 AM
Government officials in London and Washington are each advancing regulatory measures concerning artificial intelligence (AI), acknowledging its societal implications.

GOOG

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • Movers
  • News

Quality Control Issues at Novo Nordisk’s Clayton Plant – Key Site for Weight-Loss, Diabetes Drug Production

By Vandana Singh
September 18, 9:50 AM
The FDA has reportedly issued a report detailing quality control lapses at Novo Nordisk A/S's (NYSE: NVO) Clayton, North Carolina plant.

NVO

Read More
2 minute read
  • Economics
  • Equities
  • Large Cap
  • Top Stories

5 Things To Know Monday About UAW Strike Against US Auto Giants

By Piero Cingari
September 18, 9:09 AM
It's the first time the UAW has simultaneously squared off against all three of Detroit's automakers — General Motors, Stellantis and Ford.

F

Read More
1 minute read
  • Biotech
  • Equities
  • FDA
  • General
  • Health Care
  • Large Cap
  • Markets
  • News

Pleasant Surprise For GSK: FDA Approves Bone Marrow Cancer Therapy Acquired Via Sierra Oncology Deal

By Vandana Singh
September 18, 6:54 AM
FDA has 

GSK

Posts pagination

Previous 1 … 210 211 212 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service